BACKGROUND AND OBJECTIVES: Fasting insulin concentrations are increasingly being used as a surrogate for insulin resistance and risk for type 2 diabetes (T2DM), although associations with adult outcomes are unclear. Our objective was to determine whether fasting insulin concentrations in childhood associate with later T2DM.
METHODS:Fasting insulin values were available from 2478 participants in the longitudinal Cardiovascular Risk in Young Finns Study at baseline age 3 to 18 years, along with data on adult T2DM (N = 84, mean age = 39.6 years).
RESULTS:Among 3-to 6-year-olds, a 1-SD increase in fasting insulin was associated with a relative risk (RR) of 2.04 (95% confidence interval [CI], 1.54-2.70) for later T2DM, which remained significant after we adjusted for BMI and parental history of T2DM. For those aged 9 to 18 years, a 1-SD increase in insulin was associated with an RR of 1.32 (95% CI, 1.06-1.65) for T2DM, but this became nonsignificant after we adjusted for BMI and parental history of T2DM. In the latter age group, a 1-SD increase in BMI was associated with an RR of 1.45 (95% CI, 1.21-1.73) for T2DM, with adjustment for insulin and parental history of T2DM not improving this association. BMI in younger children was not associated with later T2DM. In life course analyses, those with T2DM had higher fasting insulin levels in early childhood and later adulthood but not in peripubertal years.CONCLUSIONS: Elevated fasting insulin concentrations in early childhood, but not adolescence, are independently associated with an elevated risk of T2DM in adulthood.
WHAT'S KNOWN ON THIS SUBJECT:Fasting insulin levels in childhood are increasingly being used as a surrogate for insulin resistance and risk of later type 2 diabetes, despite only a moderate correlation with whole-body insulin sensitivity and few data related to adult outcomes.
WHAT THIS STUDY ADDS:Elevated insulin values between the ages of 3 and 6 years are associated with an elevated risk for later type 2 diabetes. In 9-to 18-year-olds, elevated BMI (but not insulin values) is associated with later type 2 diabetes. Drs Sabin and Magnussen contributed equally to the study. Dr Sabin conceptualized the study, analyzed the data, and drafted the initial manuscript; Drs Magnussen and Juonala analyzed the data and assisted in writing core aspects of the manuscript; Professor Shield provided critical analysis of the findings and interpretation; Drs KÀhönen, LehtimÀki, Rönnemaa, Knip, and Hutri-KÀhönen and Professor Viikari collected the study data; Dr Koskinen and Professor Dwyer provided critical analysis of the findings and interpretation; Dr Loo collected the study data and provided data related to the correction of insulin values over time; Professor Raitakari led the study and was involved in all aspects of the study including conceptualization, data collection, analysis, and interpretation; and all authors approved the final manuscript as submitted. With the high prevalence of childhood obesity, pediatricians are routinely encountering obese patie...